| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
3,056 |
1,698 |
$2.35M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
9,076 |
6,913 |
$428K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
4,513 |
3,838 |
$241K |
| J9035 |
Injection, bevacizumab, 10 mg |
4,913 |
2,769 |
$168K |
| 92134 |
|
8,359 |
6,735 |
$147K |
| 92250 |
|
4,343 |
3,770 |
$88K |
| 1036F |
|
6,449 |
5,624 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
57 |
51 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
164 |
124 |
$4K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
13 |
12 |
$953.82 |
| 2022F |
|
1,251 |
1,103 |
$475.00 |
| 5010F |
|
1,495 |
1,313 |
$450.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
6,524 |
5,691 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
1,437 |
1,261 |
$0.00 |